Abstract:Five new type binuclear platinum(II) complexes (a–e) have been synthesized and characterized by elemental analysis, conductivity, thermal analysis, IR, UV, 1H NMR and mass spectral techniques. The cytotoxicity of the complexes was tested by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and sulforhodamine B (SRB) assays. The acute toxicity and antitumor activity of complex e in vivo were also studied. The results indicate that complexes a–d have no activity against HL-60, MCF-7, BGC-823, EJ and HCT-8 cell lines, with a higher IC50 value (>50μM). Complex e confers substantially greater cytotoxicity against HL-60, MCF-7, BGC-823, EJ and HCT-8 cell lines with an IC50 value of 0.02±0.009, 1.70±0.21, 4.00±0.35, 0.98±0.02 and 1.02±0.21μM, respectively. LD50 of complex e is 815.3mg/kg, it was significantly higher than that of cisplatin and carboplatin. Complex e at dose of 4, 12 and 20mg/kg has no activity against mouse hepatocarcinoma H22 and Lewis lung carcinoma in mice, but displays significant activity against human ovarian carcinoma A2780 and human colon carcinoma HCT-116 in nude mice at dose of 12mg/kg, and activity is similar to that of cisplatin at dose of 4mg/kg. Complex e at dose of 20mg/kg has no activity against human lung adenocarcinoma A549 in nude mice (P>0.05). The results suggest that the species of amine for the new type binuclear platinum complexes have important effect on their cytotoxicity, and they may be a new class platinum anticancer drugs.

Synthesis and Antitumor Activity of cis-Platinum(Ⅱ) Type Complexes Containing Alkoxylethoxylacetate Groups

Synthesis and antitumor activity of cis-platinum (II) type complexes containing alkoxylethoxylacetate groups

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.

In Vitro Cytotoxicity Study on Platinum(Ⅱ) Complexes with Alkoxycarboxylates As Leaving Groups

Novel Cisplatin-Type Platinum Complexes and Their Cytotoxic Activity

In vitro cytotoxicity activity of platinum(II) complexes with alkyl-branched/cyclic alkoxyacetates as leaving ligands

In Vitro Cytotoxicity Study On Platinum(Ii) Complexes With Alkoxycarboxylates As Leaving Groups

Synthesis and Biological Evaluation of Platinum(ii) Complexes Containing (1R,2r)-N1-alkyl-1,2-diaminocyclohexane and D-(+)-camphorate Ligands

Synthesis and antitumor activities in vitro of a series of platinum (II) complexes with 2-methoxyethylamine

Synthesis and in Vitro Cytotoxicity of Novel Hydrophilic Chiral 2-Alkoxy-1,4-butanediamine Platinum (II) Complexes.

Novel Hydrophilic Cis-Bis(Cyclopentylamine)Platinum(Ii) Complexes: Synthesis, Characterization, Antitumor Activity and Interaction with Dna

Antitumor Platinum(ii) Complexes of N-monoalkyl-1R, 2R-Diaminocyclohexane Derivatives with Alkyl Groups As Hindrance.

Anticancer Potency of Platinum(Ii) Complexes Containing Both Chloride Anion and Chelated Carboxylate As Leaving Groups

Antitumor Platinum(II) Complexes with 1,10-phenanthroline and Hydrophilic Alkoxyacetates as Ligands.

Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.

Synthesis, invitro Cytotoxicity, and Interaction with DNA of Platinum(II) Complexes with N-Monocycloalkyl Derivatives of 1R,2R-Diaminocyclohexane as Carrier Ligands

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Synthesis, Cytotoxicity, And Interaction With Dna Of Platinum(Ii) Complexes Of (1r,2r)-N-1-2-Amyl-1,2-Diaminocyclohexane

Synthesis, Characterization and Antitumor Activity of New Type Binuclear Platinum(ii) Complexes.

Synthesis and biological evaluation of water-soluble trans-[bicyclo[2.2.2]octane-7R,8R-diamine]platinum(II) complexes with linear or branched alkoxyacetates as leaving groups